•  Live Chat
  •  1-800-399-VETS
  • Case Studies

    Gleostine (lomustine) FDA-Approved Human Drug Has Been Reported Useful for the Management of Malignant Tumors in Cats

    Lomustine (GleostineTM) has been reported to be an effective first- and second-line chemotherapy treatment for tumor-bearing cats. The optimal reported dosing schedule is 50–60 mg/m2 PO every six weeks. Lomustine-induced hepatoxicity in cats is minimal compared to that observed in dogs. Compounded lomustine capsules should not be used because recent findings indicate that many sources ...


    Gleostine (lomustine) FDA-Approved Human Drug Has Been Reported Useful for Managing Malignant Tumors in Dogs

    Lomustine (GleostineTM) has been reported to be an effective first- and second-line chemotherapy treatment for tumor-bearing dogs. The most frequently reported toxicoses have been delayed myelosuppression, in particular neutropenia, and an elevation in serum liver enzyme laboratory values. These toxicities were reversible with supportive therapy and lomustine treatment cessation ...

    News Bulletins

    Elementos PureCare: jogo de lençóis Lumen® Premium Celliant®: A primeira coleção de artigos de cama que usa Celliant para aumentar o conforto e promover uma rápida recuperação durante o sono.LOS ANGELES, 25 de julho de 2017 /PRNewswire/ -- A Hologenix, LLC, fabricante da Celliant, a tecnologia têxtil reativa clinicamente testada mais avançada do mundo, anunciou hoje que a U.S. Food and Drug Administration (FDA) determinou que os produtos Celliant são dispositivos médicos e...


    LOS ANGELES, July 25, 2017 /PRNewswire-USNewswire/ -- On the eve of trial, Bio Pharma giant, Celgene Corporation, has agreed to pay $280 million to resolve allegations it sold and promoted its blockbuster drugs, Thalomid and Revlimid, in violation of federal and state laws. The case,...


    InteliSys Health aligns the needs of patients, providers and payors within the industry’s first real-time prescription transparency platform. Unifying actionable data and predictive analytics, this technology delivers the lowest prescription costs and opportunities for improved medication adherence. InteliSys Health provides an intelligent, transparent view of prescription drug pricing, drug fills and refills, and alternative drug therapies within the e-Prescribing workflow. (PRNewsfoto/InteliSys Health)SAN DIEGO, July 25, 2017 /PRNewswire/ -- InteliSys Health™, pioneer of the first real-time prescription transparency platform, announced today that is has been selected as a finalist in this year's Fierce Innovation Awards: Healthcare Edition 2017, an awards program from the publisher of...


    SAN DIEGO, July 25, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) will announce corporate and financial results for the second quarter 2017 on Tuesday, August 8th after the market closes.  Following the announcement, Orexigen will provide a business update and discuss the...


    Penumbra, Inc. Logo (PRNewsFoto/Penumbra, Inc.)ALAMEDA, Calif., July 25, 2017 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity 37th Annual Growth Conference in Boston, MA on Wednesday, August 9, 2017.  Event:...


    Copyright © 2015 Amatheon Inc. All Rights Reserved. Privacy Policy |  Terms of Use | Store Policy
    livechat